Clinical Trial Update: Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy

View source ↗

Summary

This update reports on a completed clinical trial investigating risk factors for arrhythmia in children and adolescents with hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hypertrophic Cardiomyopathy (HCM) | Status: COMPLETED